{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:06:43Z","timestamp":1787242003593,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00415-020-09869-2","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T20:03:03Z","timestamp":1588795383000},"page":"2589-2593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy"],"prefix":"10.1007","volume":"267","author":[{"given":"Jiaqi","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangna","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"key":"9869_CR1","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"issue":"8","key":"9869_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","volume":"9","author":"M Reindl","year":"2013","unstructured":"Reindl M, Di Pauli F, Rost\u00e1sy K et al (2013) The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 9(8):455\u2013461","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"9869_CR3","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B, McKeon A, Hinson SR et al (2016) Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 73(11):1297\u20131307","journal-title":"JAMA Neurol"},{"issue":"8","key":"9869_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.braindev.2013.10.005","volume":"36","author":"K Miya","year":"2014","unstructured":"Miya K, Takahashi Y, Mori H (2014) Anti-NMDAR autoimmune encephalitis. Brain Dev 36(8):645\u2013652","journal-title":"Brain Dev"},{"key":"9869_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.msard.2018.12.036","volume":"28","author":"T Liu","year":"2019","unstructured":"Liu T, Chen B, Yang H et al (2019) Screening for autoantibodies in inflammatory neurological syndrome using fluorescence pattern in a tissue-based assay: cerebrospinal fluid findings from 793 patients. Mult Scler Relat Disord 28:177\u2013183","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"9869_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer MJ, H\u00f6ftberger R, Iizuka T et al (2014) Overlapping demyelinating syndromes and anti-N-methyl-d-aspartate receptor encephalitis. Ann Neurol 75(3):411\u2013428","journal-title":"Ann Neurol"},{"key":"9869_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3389\/fneur.2019.01271","volume":"10","author":"Y Ren","year":"2019","unstructured":"Ren Y, Chen X, He Q et al (2019) Co-occurrence of anti-N-methyl-d-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein inflammatory demyelinating diseases: a clinical phenomenon to be taken seriously. Front Neurol 10:1271","journal-title":"Front Neurol"},{"issue":"1","key":"9869_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1471-4159.1989.tb10930.x","volume":"52","author":"C Brunner","year":"1989","unstructured":"Brunner C, Lassmann H, Waehneldt TV et al (1989) Differential ultrastructural localization of myelin basic protein, myelin\/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J Neurochem 52(1):296\u2013304","journal-title":"J Neurochem"},{"issue":"6","key":"9869_CR9","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1046\/j.1471-4159.1994.63062353.x","volume":"63","author":"D Pham-Dinh","year":"1994","unstructured":"Pham-Dinh D, Allinquant B, Ruberg M et al (1994) Characterization and expression of the cDNA coding for the human myelin\/oligodendrocyte glycoprotein. J Neurochem 63(6):2353\u20132356","journal-title":"J Neurochem"},{"issue":"1","key":"9869_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1471-4159.1999.0720001.x","volume":"72","author":"TG Johns","year":"1999","unstructured":"Johns TG, Bernard CC (1999) The structure and function of myelin oligodendrocyte glycoprotein. J Neurochem 72(1):1\u20139","journal-title":"J Neurochem"},{"issue":"5","key":"9869_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.neurad.2019.06.001","volume":"46","author":"M Den\u00e8ve","year":"2019","unstructured":"Den\u00e8ve M, Biotti D, Patsoura S et al (2019) MRI features of demyelinating disease associated with anti-MOG antibodies in adults. J Neuroradiol 46(5):312\u2013318","journal-title":"J Neuroradiol"},{"issue":"1","key":"9869_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius S, Paul F, Aktas O et al (2018) MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 15(1):134","journal-title":"J Neuroinflammation"},{"issue":"2","key":"9869_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA et al (2017) Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol 81(2):298\u2013309","journal-title":"Ann Neurol"},{"key":"9869_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fneur.2018.00251","volume":"9","author":"X Yang","year":"2018","unstructured":"Yang X, Xu H, Ding M et al (2018) Overlapping autoimmune syndromes in patients with glial fibrillary acidic protein antibodies. Front Neurol 9:251","journal-title":"Front Neurol"},{"issue":"9","key":"9869_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/jnnp-2018-318231","volume":"89","author":"A Uzawa","year":"2018","unstructured":"Uzawa A, Mori M, Kuwabara S (2018) MOG antibody disorders and AQP4 antibody NMO spectrum disorders share a common immunopathogenesis. J Neurol Neurosurg Psychiatry 89(9):100","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7374","key":"9869_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10554","volume":"479","author":"K Berer","year":"2011","unstructured":"Berer K, Mues M, Koutrolos M et al (2011) Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479(7374):538\u2013541","journal-title":"Nature"},{"issue":"4","key":"9869_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","volume":"75","author":"Y Hacohen","year":"2018","unstructured":"Hacohen Y, Wong YY, Lechner C et al (2018) Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody\u2013associated disease. JAMA Neurol 75(4):478\u2013487","journal-title":"JAMA Neurol"},{"issue":"2","key":"9869_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","volume":"89","author":"S Ramanathan","year":"2018","unstructured":"Ramanathan S, Mohammad S, Tantsis E et al (2018) Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry 89(2):127\u2013137","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"9869_CR19","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR et al (2017) Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140(12):3128\u20133138","journal-title":"Brain"},{"issue":"1","key":"9869_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflamm 13(1):279","journal-title":"J Neuroinflamm"},{"issue":"1","key":"9869_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40478-019-0786-3","volume":"7","author":"F Tea","year":"2019","unstructured":"Tea F, Lopez JA, Ramanathan S et al (2019) Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination. Acta Neuropathol Commun 7(1):145","journal-title":"Acta Neuropathol Commun"},{"key":"9869_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.msard.2019.01.036","volume":"29","author":"X Yang","year":"2019","unstructured":"Yang X, Huang Q, Yang H et al (2019) Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack. Mult Scler Relat Disord 29:94\u201399","journal-title":"Mult Scler Relat Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-09869-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T19:40:54Z","timestamp":1620330054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-09869-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["9869"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09869-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"assertion":[{"value":"25 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The present study was approved by the local ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards statement"}},{"value":"Written informed consent was obtained from the patient for the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}